These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19540115)

  • 1. Discovery of N-[(1-aryl-1H-indazol-5-yl)methyl]amides derivatives as smoothened antagonists for inhibition of the hedgehog pathway.
    Dessole G; Branca D; Ferrigno F; Kinzel O; Muraglia E; Palumbi MC; Rowley M; Serafini S; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4191-5. PubMed ID: 19540115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.
    Peukert S; Jain RK; Geisser A; Sun Y; Zhang R; Bourret A; Carlson A; Dasilva J; Ramamurthy A; Kelleher JF
    Bioorg Med Chem Lett; 2009 Jan; 19(2):328-31. PubMed ID: 19091559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.
    Muraglia E; Ontoria JM; Branca D; Dessole G; Bresciani A; Fonsi M; Giuliano C; Llauger Bufi L; Monteagudo E; Palumbi MC; Torrisi C; Rowley M; Steinkühler C; Jones P
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5283-8. PubMed ID: 21802943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
    Humphries PS; Benbow JW; Bonin PD; Boyer D; Doran SD; Frisbie RK; Piotrowski DW; Balan G; Bechle BM; Conn EL; Dirico KJ; Oliver RM; Soeller WC; Southers JA; Yang X
    Bioorg Med Chem Lett; 2009 May; 19(9):2400-3. PubMed ID: 19346127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors.
    Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based design, synthesis, biological evaluation, and SAR of 1H-benzo[d]imidazol-2-yl)-1H-indazol derivatives as potent PDK1 inhibitors.
    Chen T; Sorna V; Choi S; Call L; Bearss J; Carpenter K; Warner SL; Sharma S; Bearss DJ; Vankayalapati H
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5473-5480. PubMed ID: 29150397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO.
    Yang B; Hird AW; Russell DJ; Fauber BP; Dakin LA; Zheng X; Su Q; Godin R; Brassil P; Devereaux E; Janetka JW
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4907-11. PubMed ID: 22704236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and structure-activity-relationship of phenyl imidazoles as potent Smoothened antagonists.
    Cheng D; Han D; Gao W; Jing Q; Jiang J; Wan Y; Englund NP; Tuntland T; Wu X; Pan S
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6573-6. PubMed ID: 23036954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
    Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
    Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists.
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1426-31. PubMed ID: 24491459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Substituted 1-phenyl-1H-indazoles with analgesic, antiinflammatory, antipyretic and local anesthetic activities.
    Mosti L; Menozzi G; Schenone P; Cervo D; Esposito G; Marmo E
    Farmaco; 1990 Apr; 45(4):415-29. PubMed ID: 2400516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.
    Laufer R; Ng G; Liu Y; Patel NK; Edwards LG; Lang Y; Li SW; Feher M; Awrey DE; Leung G; Beletskaya I; Plotnikova O; Mason JM; Hodgson R; Wei X; Mao G; Luo X; Huang P; Green E; Kiarash R; Lin DC; Harris-Brandts M; Ban F; Nadeem V; Mak TW; Pan GJ; Qiu W; Chirgadze NY; Pauls HW
    Bioorg Med Chem; 2014 Sep; 22(17):4968-97. PubMed ID: 25043312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
    Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.
    Cole AG; Stroke IL; Qin LY; Hussain Z; Simhadri S; Brescia MR; Waksmunski FS; Strohl B; Tellew JE; Williams JP; Saunders J; Appell KC; Henderson I; Webb ML
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5420-3. PubMed ID: 18815029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Preliminary Cytotoxicity Studies of 1-[1-(4,5-Dihydrooxazol- 2-yl)-1H-indazol-3-yl]-3-phenylurea and 3-phenylthiourea Derivatives.
    Kornicka A; Saczewski F; Bednarski PJ; Korcz M; Szumlas P; Romejko E; Sakowicz A; Sitek L; Wojciechowska M
    Med Chem; 2017; 13(7):616-624. PubMed ID: 28266278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of NVP-LEQ506, a second-generation inhibitor of smoothened.
    Peukert S; He F; Dai M; Zhang R; Sun Y; Miller-Moslin K; McEwan M; Lagu B; Wang K; Yusuff N; Bourret A; Ramamurthy A; Maniara W; Amaral A; Vattay A; Wang A; Guo R; Yuan J; Green J; Williams J; Buonamici S; Kelleher JF; Dorsch M
    ChemMedChem; 2013 Aug; 8(8):1261-5. PubMed ID: 23821351
    [No Abstract]   [Full Text] [Related]  

  • 18. Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth.
    Remsberg JR; Lou H; Tarasov SG; Dean M; Tarasova NI
    J Med Chem; 2007 Sep; 50(18):4534-8. PubMed ID: 17685505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M3 muscarinic acetylcholine receptor antagonists: SAR and optimization of bi-aryl amines.
    Budzik B; Wang Y; Shi D; Wang F; Xie H; Wan Z; Zhu C; Foley JJ; Nuthulaganti P; Kallal LA; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Laine DI; Jin J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1686-90. PubMed ID: 19243945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-substituted 1-methyl-1H-indazoles with analgesic, antiinflammatory and antipyretic activities.
    Mosti L; Menozzi G; Fossa P; Schenone P; Lampa E; Parrillo C; D'Amisco M; Rossi F
    Farmaco; 1992 May; 47(5):567-84. PubMed ID: 1388602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.